Perphenazine versus low‐potency first‐generation antipsychotic drugs for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, October 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (76th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 14 X users

Citations

dimensions_citation: 21 Dimensions

Readers on

mendeley: 125 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 21 publications that cite this research output.

21

The most recent citing publications are shown below. View all 21 publications that cite this research output on Dimensions.

Perphenazine in Treatment-Resistant Schizophrenia

Article in Cureus (January 2024)

Green Synthetic Strategies and Pharmaceutical Applications of Thiazine and its Derivatives: An Updated Review

Article in Current Pharmaceutical Biotechnology (January 2024)

Risk Stratification of QTc Prolongation in Critically Ill Patients Receiving Antipsychotics for the Management of Delirium Symptoms.

Article in Journal of Intensive Care Medicine (December 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.